Lipid nanoparticles loaded with 10-hydroxycamptothecin–phospholipid complex developed for the treatment of hepatoma in clinical application

References

• Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet JP, Couvreur P. (1990). Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother Pharmacol, 26, 122–126.
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. (2009). Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm, 71, 161–172.
   PubMed Web of Science ®Google Scholar
• Kathryn CP, Gregory ML, Samuel AW. (2008). Exploiting lipid raft transport with membrane targeted nanoparticles: A strategy for cytosolic drug delivery. Biomaterials, 29, 3367–3375.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang Y, Feng N, Fan Z, Sun J, Nan Y. (2008). Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma. J Drug Target, 16, 725–732.
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, Ahamed HN, Saha BP, Mukherjee PK. (2005). Enhanced therapeutic benefit of quercetin–phospholipid complex in carbon tetrachloride induced acute liver injury in rats: a comparative study. Iran J Pharmacol Ther, 4, 84–90.
   Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm, 330, 155–163.
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55–63.
   PubMed Web of Science ®Google Scholar
• O’Leary J, Muggia FM. (1998). Camptothecins: a review of their development and schedules of administration. Eur J Cancer, 34, 1500–1508.
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Yokoyama M, Watanabe M, Kawano K, Maitani Y, Okano T. (2004). Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res, 21, 2001–2008.
   PubMed Web of Science ®Google Scholar
• Rivory LP, Robert J. (1995). Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives. Pharmacol Ther, 68, 269–296.
   PubMed Web of Science ®Google Scholar
• Shao K, Hou Q, Duan W, Go ML, Wong KP, Li QT. (2006). Intracellular drug delivery by sulfatide-mediated liposomes to gliomas. J Control Release, 115, 150–157.
   PubMed Web of Science ®Google Scholar
• Soma CE, Dubernet C, Barratt G, Benita S, Couvreur P. (2000). Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro. J Control Release, 68, 283–289.
   PubMed Web of Science ®Google Scholar
• Stoye I, Schröder K, Müller-Goymann CC. (1998). Transformation of a liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles—physico-chemical characterization and influence on drug permeation through excised human stratum corneum. Eur J Pharm Biopharm, 46, 191–200.
   PubMed Web of Science ®Google Scholar
• Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. (1966). Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumour inhibitor from camptotheca acuminata. J Am Chem Soc, 88, 3888–3890.
   Web of Science ®Google Scholar
• Wei W, Zhao D, Zhang ZR, Gong T. (2008). Study on the physico-chemical properties of hydroxycamptothecin-phospholipid complex. West China J Pharm Sci, 23, 396–399.
   Google Scholar
• Wu Y, He W, Dai WB, Zhou BH, Song JC. (2005). Study on formulation and preparation of chitosan chloride coated hydroxycamptothecin nanoliposomes. Chin Pharm J, 40, 922–925.
   Google Scholar
• Xiao YY, Song YM, Chen ZP, Ping QN. (2006). The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 307, 77–82.
   PubMed Web of Science ®Google Scholar
• Xiong XB, Huang Y, Lu WL, Zhang X, Zhang H, Nagai T, Zhang Q. (2005). Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release, 107, 262–275.
   PubMed Web of Science ®Google Scholar
• Yang L, Cui F, Cun D, Tao A, Shi K, Lin W. (2007). Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm, 340, 163–172.
   PubMed Web of Science ®Google Scholar
• Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release, 59, 299–307.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ding Y, Yu LL, Ping Q. (2007). Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives. Colloids Surf B Biointerfaces, 55, 192–199.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. (2004). Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release, 96, 135–148.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang M, Wang Q, Li Y, Guo R, Jiang X, Yang C, Liu B. (2007). 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J Control Release, 119, 153–162.
   PubMed Web of Science ®Google Scholar
• Zhang XX, Gan Y, Yang XG, Zhu CL, Gan L, Nie SF, Pan WS. (2008). [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Yao Xue Xue Bao, 43, 91–96.
   PubMedGoogle Scholar
• Zhao D, Gong T, Fu Y, Nie Y, He LL, Liu J, Zhang ZR. (2008). Lyophilized Cheliensisin A submicron emulsion for intravenous injection: characterization, in vitro and in vivo antitumor effect. Int J Pharm, 357, 139–147.
   PubMedGoogle Scholar
• Zhao YZ, Luo YK, Liang HD, Mei XG, Tang J, Lu CT, Zhang Y, Lin Q. (2006). Comparing transfection efficiency and safety for antisense oligodeoxyribonucleotide between phospholipids-based microbubbles and liposomes. J Drug Target, 14, 687–693.
   PubMed Web of Science ®Google Scholar